Abstract
By 2022, the number of survivors is expected to grow to nearly 18 million. Therefore, addressing acute and chronic negative sequelae of a cancer diagnosis and its treatments becomes a health imperative. For women with a history of breast cancer, one of the common goals of treatment and prevention of recurrence is to reduce circulating concentrations of estradiol, especially in women with hormone receptor positive breast cancer. Hormone deprivation after a diagnosis of breast cancer impacts physiological targets other than in the breast tissue and can result in unwanted side effects, all of which can negatively impact quality of life and function and cause distress. Symptoms that are most strongly linked by evidence to hormone changes after cancer diagnosis and treatment include hot flashes, night sweats, sleep changes, fatigue, mood changes, and diminishing sexual function, including vaginal atrophy (decreased arousal, dryness and dyspareunia), infertility, decreased desire and negative self-image. Weight gain and resulting body image changes are often concomitants of the abrupt onset of treatment-induced menopause.
The purpose of this chapter is to briefly review what is known about the advent of premature menopause in women treated for breast cancer, menopausal symptoms that are exacerbated by endocrine treatments for breast cancer, and the associated concerns of hot flashes and related menopausal symptoms, sexual health and fertility issues. We will discuss limitations in the current research and propose strategies that address current limitations in order to move the science forward.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Andersen BL, Carpenter KM, Yang HC, Shapiro CL (2007) Sexual well-being among partnered women with breast cancer recurrence. J Clin Oncol 25(21):3151–3157
Appt SE, Ethun KF (2010) Reproductive aging and risk for chronic disease: Insights from studies of nonhuman primates. Maturitas 67(1):7–14
Ayers B, Smith M, Hellier J, Mann E, Hunter MS (2012) Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized trial. Menopause 19(7):749–759
Azim HA Jr, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H, Peccatori FA (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer 47(1):74–83
Azim HA Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen MB, Cordoba O, de Azambuja E, Goldhirsch A, Piccart MJ, Peccatori FA (2013) Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study. J Clin Oncol 31(1):73–79
Balabanovic J, Ayers B, Hunter MS (2012) Women’s experiences of group cognitive behaviour therapy for hot flushes and night sweats following breast cancer treatment: an interpretative phenomenological analysis. Maturitas 72(3):236–242
Bardia A, Novotny P, Sloan J, Barton D, Loprinzi C (2009) Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis. Menopause 16(3):477–483
Barton D, Loprinzi CL (2004) Making sense of the evidence regarding nonhormonal treatments for hot flashes. Clin J Oncol Nurs 8(1):39–42
Barton DLC, Atherton P, Sloan J, Dalton R, Balcueva E, Carpenter P (2007a) The significance of serum testosterone concentrations from female cancer survivors. Oncol Nurs Forum 34(1):170
Barton DL, Wender DB, Sloan JA, Dalton RJ, Balcueva EP, Atherton PJ, Bernath AM Jr, DeKrey WL, Larson T, Bearden JD 3rd, Carpenter PC, Loprinzi CL (2007b) Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst 99(9):672–679
Barton DTA, Atherton P, Collins M, Sloan J (2009) The menopausal experience of premenopausal women receiving adjuvant chemotherapy for breast cancer. Oncol Nurs Forum 36(3):21–22
Barton DL, Thompson SL, Senn-Reeves JN, Satele DV, Frost M (2012) Effects of chemotherapy on the ovary: what you didn’t know. Cancer Res 72(24 Suppl 3):2-11-01
Barton D, Fee-Schroeder K, Linquist B, Keith T, Wolf S, Abboud L, Elkins G (2013) Pilot study of a biobehavioral treatment for hot flashes. Ann Behav Med 45(S33):Abstract A-130
Basson R (2010) Sexual function of women with chronic illness and cancer. Womens Health (Lond Engl) 6(3):407–429
Baynosa J, Westphal LM, Madrigrano A, Wapnir I (2009) Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. J Am Coll Surg 209(5):603–607
Bertero C, Chamberlain Wilmoth M (2007) Breast cancer diagnosis and its treatment affecting the self: a meta-synthesis. Cancer Nurs 30(3):194–202, quiz 203–204
Biglia N, Moggio G, Peasno E, Sgandurra P, Ponzone R, Nappi RE, Sismondi P (2010) Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. J Sex Med 7(5):1891–1900
Braunstein GD, Sundwall DA, Katz J, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB (2005) Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 165(14):1582–1589
Brotto LA, Yule M, Breckon E (2010) Psychological interventions for the sexual sequelae of cancer: a review of the literature. J Cancer Surviv 4(4):346–360
Buijs C, de Vries EG, Mourits MJ, Willemse PH (2008) The influence of endocrine treatments for breast cancer on health-related quality of life. Cancer Treat Rev 34(7):640–655
Burwell SR, Case LD Kaelin C, Avis NE (2006) Sexual problems in younger women after breast cancer surgery. J Clin Oncol 24(18):2815–2821
Busby D, Christensen C, Crane R, Larson J (1995) A revision of the dyadic adjustment scale for use with distressed and nondistressed couples: construct hierarchy and multidimensional scales. J Marital Fam Ther 21(3):289–303
Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P. (2005) Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 105(5 Pt 1):944–952
Chudakov B, Ben Zion IZ, Belmaker RH (2007) Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the Arizona sexual experiences scale for females and sexual function questionnaire. J Sex Med 4(1):204–208
Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396
Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL (2002) Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard study of moods and cycles. J Affect Disord 70(2):125–132
Curran S, Andrykowsky M, Studts J (1995) Short form of the profile of mood states (POMS-SF): psychometric information. Psychol Assess 7(1):80–83
Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW (2006) Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 13(3):387–396
Davis S, Papalia MA, Norman RJ, O’Neill S, Redelman M, Williamson M, Stuckey BG, Wlodarczyk J, Gard’ner K, Humberstone A (2008a) Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med 148(8):569–577
Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J, Aphrodite Study Team (2008b) Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 359(19):2005–2017
deMoor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, Forsythe L, Scoppa S, Hachey M, Rowland JH (2013) Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev 22(4):561–570
Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, Lee K, Miaskowski C, Puntillo K, Rankin S, Taylor D (2001) Advancing the science of symptom management. J Adv Nurs 33(5):668–676
Dodd MJ, Cho MH, Cooper B, Miaskowski C, Lee KA, Bank K (2005) Advancing our knowledge of symptom clusters. J Support Oncol 3(6 Suppl 4):30–31
Duffy CM, Allen SM, Clark MA (2005) Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23(4):766–773
Duijts SF, van Beurden M, Oldenburg HS, Hunter MS, Kieffer JM, Stuiver MM, Gerritsma MA, Menke-Pluymers MB, Plaisier PW, Rijna H, Lopes Cardozo AM, Timmers G, van der Meij S, van der Veen H, Bijker N, de Widt-Levert LM , Geenen MM, Heuff G, van Dulken EJ, Boven E, Aaronson NK (2012) Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. J Clin Oncol 30(33):4124–4133
Elkins GR, Fisher WL, Johnson AK, Carpenter JS, Keith TZ (2013) Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause 20(3):291–298
Fobair P, Spiegel D (2009) Concerns about sexuality after breast cancer. Cancer J 15(1):19–26
Freedman RR (2001) Physiology of hot flashes. Am J Hum Biol 13(4):453–464
Freedman RR, Roehrs TA (2007) Sleep disturbance in menopause. Menopause 14(5):826–829
Freedman RR, Kruger ML, Wasson SL (2011) Heart rate variability in menopausal hot flashes during sleep. Menopause 18(8):897–900
Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S (2008) Symptoms in the menopausal transition: hormone and behavioral correlates. Obstet Gynecol 111(1):127–136
Frierson G, Thiel D, Andersen B (2006) Body change stress for women with breast cancer: the breast-impact of treatment scale. Ann Behav Med 32(1):77–81
Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16(2):501–514
Ganz PA, Desmond KA, Belin TR, Meyerowitz BE, Rowland JH (1999) Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol 17(8):2371–2380
Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR (2000) Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 92(13):1054–1064
Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21(22):4184–4193
Ganz PA, Land SR, Geyer CE Jr, Cecchini RS, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff JA, Vogel VG, Erban JK, Livingston RB, Perez EA, Mamounas EP, Wolmark N, Swain SM (2011) Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. J Clin Oncol 29(9):1110–1116
Gibbs Z, Lee S, Kulkarni J (2013) Factors associated with depression during the perimenopausal transition. Womens Health Issues 23(5):e301–e307
Gilbert E, Ussher JM, Perz J (2010) Sexuality after breast cancer: a review. Maturitas 66(4):397–407
Goldfarb S, Muhall J, Nelson C, Kelvin J, Dickler M, Carter J (2013) Sexual and reproductive health in cancer survivors. Semin Oncol 40(6):726–744
Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR (2003) Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 10(5):390–398
Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N (1999) Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 17(1):120–129
Gracia CR, Freeman EW (2004) Acute consequences of the menopausal transition: the rise of common menopausal symptoms. Endocrinol Metab Clin North Am 33(4):675–689
Gracia CR, Freeman EW, Sammel MD, Lin H, Mogul M (2007) Hormones and sexuality during transition to menopause. Obstet Gynecol 109(4):831–840
Hale GE, Burger HG (2009) Hormonal changes and biomarkers in late reproductive age, menopausal transition and menopause. Best Pract Res Clin Obstet Gynaecol 23(1):7–23
Harlow SD, Karvonen C, Bromberger J, Cauley J, Gold E, Matthews K (2013) Menopause: its epidemiology in women and health. Elsevier, Amsterdam
Howard-Anderson J, Ganz PA, Bower JE, Stanton AL (2012) Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 104(5):386–405
Hunter M, Rendall M (2007) Bio-psycho-socio-cultural perspectives on menopause. Best Pract Res Clin Obstet Gynaecol 21(2):261–274
Kao A, Binik YM, Amsel R, Funaro D, Leroux N, Khalife S (2012) Biopsychosocial predictors of postmenopausal dyspareunia: the role of steroid hormones, vulvovaginal atrophy, cognitive-emotional factors, and dyadic adjustment. J Sex Med 9(8):2066–2076
Kim E, Jahan T, Aouizerat BE, Dodd MJ, Cooper BA, Paul SM, West C, Lee K, Swift PS, Wara W, Miaskowski C (2009) Changes in symptom clusters in patients undergoing radiation therapy. Support Care Cancer 17(11):1383–1391
Kroman N, Jensen MB, Wohlfahrt J, Ejlertsen B, Danish Breast Cancer Cooperative Group (2008) Pregnancy after treatment of breast cancer–a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol 47(4):545–549
Krychman M, Millheiser LS (2013) Sexual health issues in women with cancer. J Sex Med 10(Suppl 1):5–15
Lambertini M, Anserini P, Levaggi A, Poggio F, Del Mastro L (2013) Fertility counseling of young breast cancer patients. J Thorac Dis 5(Suppl 1):S68–S80
Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH (2006) Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 17(12):1777–1782
Lenz ER, Pugh LC, Milligan RA, Gift A, Suppe F (1997) The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci 19(3):14–27
Lester J, Bernhard L, Ryan-Wenger N (2012) A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivors. West J Nurs Res 34(1):72–96
Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Dakhil SR, Verdirame JD, Knutson WH, Kelaghan J, Christensen B (2008) Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause 15(4 Pt 1):655–660
Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P (2009) Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 27(17):2831–2837
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Patriddge AH, Quinn G, Wallace WH, Oktay K, American Society of Clinical Oncology (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(19):2500–2510
Malinovszky KM, Gould A, Foster E, Cameron D, Humphreys A, Crown J, Leonard RC, Anglo Celtic Co-operative Oncology Group (2006) Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer 95(12):1626–1631
Mann E, Smith MJ, Hellier J, Balabanovic JA, Hamed H, Grunfeld EA, Hunter MS (2012) Cognitive behavioral treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomized controlled trial. Lancet Oncol 13(3):309–318
Miaskowski C, Aouizerat BE, Dodd M, Cooper B (2007) Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer. J Natl Cancer Inst Monogr 37:39–46
Murthy V, Chamberlain R (2012) Menopausal symptoms in young survivors of breast cancer: a growing problem without an ideal solution. Cancer Control 19(4):317–329
Nappi RE, Albani F, Santamaria V, Tonani S, Magri F, Martini E, Chiovato L., Polatti F (2010) Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause. Maturitas 67(1):78–83
Nathorst-Böös J, Flöter A, Jarkander-Rolff M, Carlström K, Schoultz Bv (2006) Treatment with percutaneous testosterone gel in postmenopausal women with decreased libido–effects on sexuality and psychological general well-being. Maturitas 53(1):11–18
Neuss MN, Malin JL, Chan S, Kadlubek PJ, Adams JL, Jacobson JO, Blayney DW, Simone JV (2013) Measuring the improving quality of outpatient care in medical oncology practices in the United States. J Clin Oncol 31(11):1471–1477
No Authors (2005) National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 142(12):1003–1013
Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A, Winer EP (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22(20):4174–4183
Phipps AI, Ichikawa L, Bowles EJ, Carney PA, Kerlikowske K, Miglioretti DL, Buist DS (2010) Defining menopausal status in epidemiologic studies: a comparison of multiple approaches and their effects on breast cancer rates. Maturitas 67(1):60–66
Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, Wilson C, Munster P (2007) Discussion of fertility preservation with newly diagnosed patients: oncologists’ views. J Cancer Surviv 1(2):146–155
Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, Keefe DL, Albrecht TL (2009) Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol 27(35):5952–5957
Reinecke JD, Kelvin JF, Arvey SR, Quinn GP, Levine J, Beck LN, Miller A (2012) Implementing a systematic approach to meeting patients’ cancer and fertility needs: a review of the Fertile Hope Centers of Excellence program. J Oncol Pract 8(5):303–308
Rissling MB, Liu L, Natarajan L, He F, Ancoli-Israel S (2011) Relationship of menopausal status and climacteric symptoms to sleep in women undergoing chemotherapy. Support Care Cancer 19(8):1107–1115
Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd (2006) Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7(10):821–828
Rogers M, Kristjanson LJ (2002) The impact on sexual functioning of chemotherapy-induced menopause in women with breast cancer. Cancer Nurs 25(1):57–65
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R Jr (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26(2):191–208
Rowland JH, Meyerowitz BE, Crespi CM, Leedham B, Desmond K, Belin TR, Ganz PA (2009) Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention. Breast Cancer Res Treat 118(1):99–111
Salonen P, Tarkka MT, Kellokumpu-Lehtinen PL, Astedt-Kurki P, Luukkaala T, Kaunonen M (2009) Telephone intervention and quality of life in patients with breast cancer. Cancer Nurs 32(3):177–190, quiz 191–192
Senkus E, Gomez H, Dirix L, Jerusalem G, Murray E, Van Tienhoven G, Westernberg AH, Bottomonley A, Rapion J, Bogaerts J, Di Leo A, Nešković-Konstantinović Z (2014) Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98. Psychooncology 23(2):173–182
Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA (2000) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343(10):682–688
Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O’Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R (2006) Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 13(5):770–779
Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA (2010) Premature menopause or early menopause: long-term health consequences. Maturitas 65(2):161–166
Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62(4):220–241
Sigmon ST, Whitcomb-Smith SR, Rohan KJ, Kendrew JJ (2004) The role of anxiety level, coping styles, and cycle phase in menstrual distress. J Anxiety Disord 18(2):177–191
Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rosenberg C, Lucas J, Davis S (2005) Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90(9):5226–5233
Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N (2001) Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 4(4):267–272
Speer JJ, Hillenberg B, Sugrue DP, Blacker C, Kresge CL, Decker VB, Zakalik D, Decker DA (2005) Study of sexual functioning determinants in breast cancer survivors. Breast J 11(6):440–447
Stone SE, Mazmanian D, Oinonen KA, Sharma V (2013) Past reproductive events as predictors of physical symptom severity during the menopausal transition. Menopause 20(8):831–839
Swain SM, Land SR, Ritter MW, Costantino JP, Cecchini RS, Manounas EP, Wolmark N, Ganz PA (2009) Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Breast Cancer Res Treat 113(2):315–320
Swain SM, Jeong JH, Geyer CE Jr, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, Perez EA, Mamounas EP, Land SR, Ganz PA, Wolmark N (2010) Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 362(22):2053–2065
Tan O, Bradshaw K, Carr BR (2012) Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review. Menopause 19(1):109–117
Taylor S, Harley C, Ziegler L, Brown J, Velikova G (2011) Interventions for sexual problems following treatment for breast cancer: a systematic review. Breast Cancer Res Treat 130(3):711–724
Thurston RC, Christie IC, Matthews KA (2012) Hot flashes and cardiac vagal control during women’s daily lives. Menopause 19(4):406–412
Tremblay A, Sheeran L, Aranda S (2008) Psychoeducational interventions to alleviate hot flashes: a systematic review. Menopause 15(1):193–202
Waimey KE, Duncan FE, Su HI, Smith K, Wallach H, Jona K, Coutifaris C, Gracia CR, Shea LD, Brannigan RE, Chang RJ, Zelinski MB, Stouffer RL, Taylor RL, Woodruff TK (2013) Future directions in oncofertility and fertility preservation: a report from the 2011 Oncofertility Consortium Conference. J Adolesc Young Adult Oncol 2(1):25–30
Ware JE Jr (2000) SF-36 health survey update. Spine 25(24):3130–3139
Westphal LM, Wapnir IL (2012) Integration and safety of fertility preservation in a breast cancer program. Gynecol Oncol 124(3):474–476
Yanikkerem E, Koltan SO, Tamay AG, Dikayak Ş (2012) Relationship between women’s attitude towards menopause and quality of life. Climacteric 15(6):552–562
Yoo C, Yun MR, Ahn JH, Jung KH, Kim HJ, Kim JE, Park JY, Park KO, Yoon DH, Kim SB (2013) Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study. Cancer Chemother Pharmacol 72(3):565–575
Young-McCaughan S (1996) Sexual functioning in women with breast cancer after treatment with adjuvant therapy. Cancer Nurs 19(4):308–319
Zibecchi L, Greendale GA, Ganz PA (2003) Continuing education: comprehensive menopausal assessment: an approach to managing vasomotor and urogenital symptoms in breast cancer survivors. Oncol Nurs Forum 30(3):393–407
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Breast Cancer Research Foundation
About this chapter
Cite this chapter
Barton, D.L., Ganz, P.A. (2015). Symptoms: Menopause, Infertility, and Sexual Health. In: Ganz, P. (eds) Improving Outcomes for Breast Cancer Survivors. Advances in Experimental Medicine and Biology(), vol 862. Springer, Cham. https://doi.org/10.1007/978-3-319-16366-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-16366-6_9
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16365-9
Online ISBN: 978-3-319-16366-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)